Efficacy of NS5A inhibitors against unusual and potentially difficult-to-treat HCV subtypes commonly found in sub-Saharan Africa and South East Asia
Dung Nguyen, David A. Smith, Alun Vaughan-Jackson, Andrea Magrì, Eleanor Barnes, Peter Simmonds
Topics & Concepts
LedipasvirNS5ADaclatasvirSofosbuvirRepliconVirologyHepatitis C virusMedicineBiologyVirusHepacivirusGeneticsGeneRibavirinPlasmidHepatitis C virus researchHIV/AIDS drug development and treatmentDiverse Scientific Research Studies